Patients' Geography Impacts Guideline-Concordant COPD Care
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 20, 2023 -- Geographical challenges to accessing care increase the likelihood of receiving guideline-discordant inhaler regimens following hospitalization for chronic obstructive pulmonary disease (COPD) exacerbation, according to a study published online in the October issue of The Lancet Regional Health: Americas.
Arianne K. Baldomero, M.D., from the Minneapolis Veterans Affairs Health Care System, and colleagues assessed patient-level differences in guideline-discordant inhaler regimens by rurality, drive time to pulmonary specialty care, and fragmented care. The analysis included 33,785 VA patients with COPD who received primary care and prescriptions (2017 to 2020).
The researchers found that 48.6 percent of patients received guideline-discordant inhaler regimens three months after hospitalization for COPD exacerbation. There were higher odds of guideline-discordant inhaler regimens among rural residents versus their urban counterparts (adjusted odds ratio, 1.18). With longer drive time to pulmonary specialty care, the odds of receiving guideline-discordant inhaler regimens increased (adjusted odds ratio, 1.38 for drive time >90 minutes versus <30 minutes). Higher odds of guideline-discordant inhaler regimens were also seen with fragmented care (adjusted odds ratio, 1.56).
"Our findings suggest the need for development of innovative programs to improve delivery of guideline-concordant COPD care, especially in high-risk COPD patients with geographic barriers to care and fragmented care," the authors write.
One author disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Researchers Compare Race-Based, Race-Neutral Lung Function Equations
TUESDAY, May 21, 2024 -- The use of race-based and race-neutral equations for lung-function testing generate similarly accurate predictions of respiratory outcomes, but differ in...
Pulmonologist Intervention Beneficial for Undiagnosed Asthma, COPD
TUESDAY, May 21, 2024 -- For adults with undiagnosed asthma and chronic obstructive pulmonary disease (COPD), receipt of pulmonologist-directed treatment is associated with less...
Dupilumab Tied to Fewer Exacerbations in COPD With Type 2 Inflammation
TUESDAY, May 21, 2024 -- Dupilumab is associated with fewer exacerbations for patients with chronic obstructive pulmonary disease (COPD) with type 2 inflammation, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.